Literature DB >> 11517396

Viruses can silently prime for and trigger central nervous system autoimmune disease.

D J Theil1, I Tsunoda, F Rodriguez, J L Whitton, R S Fujinami.   

Abstract

Although many viruses have been isolated from patients with multiple sclerosis (MS), as yet, no one agent has been demonstrated to cause MS. In contrast, epidemiological data indicate that viral infections are associated with exacerbations of MS. Here, we present data showing that virus infections can subclinically prime animals for central nervous system (CNS) autoimmune disease; long after the original infection has been eradicated, a nonspecific challenge/infection can trigger an exacerbation. The priming infectious agent must show molecular mimicry with self-CNS antigens such as glial fibrillary acidic protein (GFAP), myelin associated glycoprotein (MAG) or myelin proteolipid protein (PLP). The subsequent challenge, however, may be nonspecific; complete Freund's adjuvant (CFA), or infection with a recombinant vaccinia virus encoding an irrelevant protein, could trigger CNS disease. In the CNS, we could detect a mononuclear cell infiltration, but no demyelination was found. However, if the pathogenesis of MS is similar to that of this novel animal model for CNS autoimmune disease, our findings could help explain why exacerbations of MS are often associated with a variety of different viral infections.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11517396     DOI: 10.1080/13550280152403263

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  49 in total

1.  Revised estimate of the prevalence of multiple sclerosis in the United States.

Authors:  D W Anderson; J H Ellenberg; C M Leventhal; S C Reingold; M Rodriguez; D H Silberberg
Journal:  Ann Neurol       Date:  1992-03       Impact factor: 10.422

Review 2.  Genetics of multiple sclerosis--how could disease-associated HLA-types contribute to pathogenesis?

Authors:  R Martin
Journal:  J Neural Transm Suppl       Date:  1997

3.  Chronic experimental allergic encephalomyelitis in guinea pigs induced by proteolipid protein.

Authors:  T Yoshimura; T Kunishita; K Sakai; M Endoh; T Namikawa; T Tabira
Journal:  J Neurol Sci       Date:  1985 May-Jun       Impact factor: 3.181

4.  Experimental autoimmune encephalomyelitis. An anatomically-based explanation of clinical progression in rodents.

Authors:  R D Simmons; C C Bernard; G Singer; P R Carnegie
Journal:  J Neuroimmunol       Date:  1982-12       Impact factor: 3.478

5.  Sequence polymorphisms in the chemokines Scya1 (TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-1), and Scya12 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis.

Authors:  C Teuscher; R J Butterfield; R Z Ma; J F Zachary; R W Doerge; E P Blankenhorn
Journal:  J Immunol       Date:  1999-08-15       Impact factor: 5.422

6.  Identification of autoimmune T cells among in vivo expanded CD25+ T cells in multiple sclerosis.

Authors:  Z Illés; T Kondo; K Yokoyama; T Ohashi; T Tabira; T Yamamura
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

7.  Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity.

Authors:  R S Fujinami; M B Oldstone
Journal:  Science       Date:  1985-11-29       Impact factor: 47.728

8.  Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study.

Authors:  O Andersen; P E Lygner; T Bergström; M Andersson; A Vahlne
Journal:  J Neurol       Date:  1993-07       Impact factor: 4.849

9.  Major histocompatibility complex class II alleles and the course and outcome of MS: a population-based study.

Authors:  B G Weinshenker; P Santrach; A S Bissonet; S K McDonnell; D Schaid; S B Moore; M Rodriguez
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

Review 10.  Tolerance and autoimmunity in TCR transgenic mice specific for myelin basic protein.

Authors:  J Goverman
Journal:  Immunol Rev       Date:  1999-06       Impact factor: 12.988

View more
  27 in total

Review 1.  Heterologous immunity between viruses.

Authors:  Raymond M Welsh; Jenny W Che; Michael A Brehm; Liisa K Selin
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  A retrospective study of non-suppurative encephalitis in beef cattle from western Canada.

Authors:  Sergio Sánchez; Edward G Clark; Gary A Wobeser; Eugene D Janzen; Hélène Philibert
Journal:  Can Vet J       Date:  2013-12       Impact factor: 1.008

Review 3.  Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.

Authors:  Robert S Fujinami; Matthias G von Herrath; Urs Christen; J Lindsay Whitton
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

4.  Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis.

Authors:  J Ludovic Croxford; Julie K Olson; Holly A Anger; Stephen D Miller
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 5.  Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.

Authors:  Liisa K Selin; Myriam F Wlodarczyk; Anke R Kraft; Siwei Nie; Laurie L Kenney; Roberto Puzone; Franco Celada
Journal:  Autoimmunity       Date:  2011-01-20       Impact factor: 2.815

Review 6.  Experimental autoimmune encephalomyelitis as a testing paradigm for adjuvants and vaccines.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Vaccine       Date:  2010-09-16       Impact factor: 3.641

Review 7.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

8.  Targeting myelin proteolipid protein to the MHC class I pathway by ubiquitination modulates the course of experimental autoimmune encephalomyelitis.

Authors:  Diethilde J Theil; Jane E Libbey; Fernando Rodriguez; J Lindsay Whitton; Ikuo Tsunoda; Tobias J Derfuss; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2008-11-15       Impact factor: 3.478

9.  Myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiency.

Authors:  Ricardo F Frausto; Stephen J Crocker; Boreth Eam; Jason K Whitmire; J Lindsay Whitton
Journal:  J Neuroimmunol       Date:  2007-10-26       Impact factor: 3.478

Review 10.  Potential triggers of MS.

Authors:  Jane E Libbey; Robert S Fujinami
Journal:  Results Probl Cell Differ       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.